Zim Laboratories Fact Sheet, Zim Laboratories Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Zim Laboratories Fact Sheet    (ZIML)


Special Report: 3 Backdoor Stocks to Play the 15x EV Opportunity


Here is the latest financial fact sheet of Zim Laboratories. For more details, see the Zim Laboratories quarterly results and Zim Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

ZIM LABORATORIES Price History

Price Rs 129.9
Mkt Cap Rs m 2,110
Vol '000 0.7
P/E X 49.9
P/CF X 11.9
EPS (TTM) Rs 2.6
% ch % 0.7
No. of shares m 16.24
% ch week % -7.1
% ch 1-mth % -6.9
% ch 12-mth % 51.0
52 week H/L Rs 189.5/68.6
(As on Oct 18, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ZIM LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
ZIM LABORATORIES EQUITY SHARE DATA
High RsNANANA480149 
Low RsNANANA11742 
Sales per share (Unadj.) Rs325.5285.3336.6208.0171.7 
Earnings per share (Unadj.) Rs6.423.123.79.52.0 
Diluted earnings per shareRs3.111.411.89.42.0 
Cash flow per share (Unadj.) Rs17.334.435.916.610.9 
Dividends per share (Unadj.) Rs1.0001.000.500 
Adj. dividends per shareRs0.490.000.500.500.00 
Avg Dividend yield %NMNMNM0.20 
Book value per share (Unadj.) Rs122.9146.5168.893.094.8 
Adj. book value per shareRs60.572.483.792.394.5 
Shares outstanding (eoy) m8.008.038.0616.1216.18 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0001.40.6 
Avg P/E ratio x00031.446.9 
P/CF ratio (eoy) x00018.08.7 
Price / Book Value ratio x0003.21.0 
Dividend payout %15.704.25.30 
Avg Mkt Cap Rs m0004,8141,544 
No. of employees `000NANANANANA 
Total wages/salary Rs m307330408483514 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ZIM LABORATORIES INCOME DATA
Net Sales Rs m2,6042,2912,7133,3542,777 
Other income Rs m3955342045 
Total revenues Rs m2,6432,3462,7483,3742,823 
Gross profit Rs m239315406420226 
Depreciation Rs m889098114144 
Interest Rs m13710593106127 
Profit before tax Rs m541752492211 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3-115867-32 
Profit after tax Rs m5118619115333 
Gross profit margin %9.213.715.012.58.1 
Effective tax rate %4.9-6.223.430.5-4,678.3 
Net profit margin %2.08.17.04.61.2 
ZIM LABORATORIES BALANCE SHEET DATA
Current assets Rs m1,5531,5381,7291,9531,820 
Current liabilities Rs m1,2371,1321,4141,5641,434 
Net working cap to sales %12.217.711.611.613.9 
Current ratio x1.31.41.21.21.3 
Inventory Days Days105261416 
Debtors Days Days12414112010189 
Net fixed assets Rs m1,0209591,2171,3241,379 
Share capital Rs m808081161162 
"Free" reserves Rs m9031,0961,2801,3381,373 
Net worth Rs m9831,1761,3601,4991,535 
Long term debt Rs m348275203222274 
Total assets Rs m2,5742,4962,9463,2773,200 
Interest coverage x1.42.73.73.11.0 
Debt to equity ratio x0.40.20.10.10.2 
Sales to assets ratio x1.00.90.91.00.9 
Return on assets %7.311.69.77.95.0 
Return on equity %5.215.814.110.22.1 
Return on capital %14.319.321.919.07.0 
Exports to sales %39.753.7062.057.6 
Imports to sales %4.26.3010.34.6 
Exports (fob) Rs m1,0351,23102,0791,600 
Imports (cif) Rs m1091440345128 
Fx inflow Rs m1,0351,23202,0791,697 
Fx outflow Rs m2953220345128 
Net fx Rs m74091001,7341,569 
ZIM LABORATORIES CASH FLOW
From Operations Rs m 219 321 367 349 219 
From Investments Rs m -117 -72 -258 -207 -191 
From Financial Activity Rs m -103 -251 -98 -152 -25 
Net Cashflow Rs m -1 -3 10 -10 10 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 33.3%
Institution 0.0%
Non-Institution 66.7%
Total 100.0%
Free Float 66.7%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Sadoday Gyan (Ground Floor) Opp. Nadt, Nelson Square, Nagpur - 440013
E-MAIL cs@zimlab.in WEB www.zimlab.in
TEL 0712-2588070 FAX
SECTOR PHARMACEUTICALS GROUP MNC
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1984 BSE CODE: 541400 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   NATCO PHARMA  LINCOLN PHAR  FERVENT SYNERGIES  PIRAMAL ENTERPRISES  LACTOSE INDIA  

Compare ZIM LABORATORIES With:   NATCO PHARMA  LINCOLN PHAR  FERVENT SYNERGIES  PIRAMAL ENTERPRISES  LACTOSE INDIA  




Today's Market

Sensex Gains 460 Points, Nifty Ends Above 18,450; Hindalco and Infosys Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 8-QTR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS